Tsumura & Co.

60
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3535800001
JPY
3,729.00
32 (0.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Tsumura & Co. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
41,036.00
45,559.00
23,736.00
23,018.00
25,563.00
20,456.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-16,797.00
-13,825.00
-22,277.00
-11,363.00
-6,659.00
-7,653.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
23,618.00
33,823.00
5,608.00
16,452.00
21,314.00
16,102.00
Cash Flow from Investing Activities
-47,623.00
-24,974.00
-19,351.00
-15,493.00
-9,111.00
215.00
Cash Flow from Financing Activities
31,017.00
-19,871.00
-4,417.00
24,423.00
-8,181.00
-17,992.00
Net Cash Inflow / Outflow
5,126.00
-4,900.00
-16,695.00
27,193.00
7,867.00
-1,544.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1,886.00
6,122.00
1,465.00
1,811.00
3,845.00
131.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Tsumura & Co.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
41036
54293
-13,257.00
-24.42%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-16797
-1045
-15,752.00
-1507.37%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
23618
33566
-9,948.00
-29.64%
Cash Flow from Investing Activities
-47623
12817
-60,440.00
-471.56%
Cash Flow from Financing Activities
31017
-33336
64,353.00
193.04%
Net Cash Inflow / Outflow
5126
13037
-7,911.00
-60.68%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1886
-10
-1,876.00
-18760.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -30.17% vs 503.12% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
23,618.00
33,823.00
-30.17%